Key result
Community-based non-pharmacological interventions for cardiovascular and kidney disease outcomes in remote Indigenous communities will be evaluated in this planned scoping review.
Why the study?
Indigenous populations face a disproportionately high burden of CVD and CKD, and a review protocol was needed to assess non-pharmacological interventions aimed at reducing these risks.
Do community-based non-pharmacological interventions reduce cardiovascular and kidney disease risk factors in remote dwelling Indigenous communities?
Do community-based non-pharmacological interventions reduce cardiovascular and kidney disease risk factors in remote dwelling Indigenous communities?
This protocol outlines a planned scoping review to evaluate the impact of non-pharmacological interventions on cardiovascular and kidney disease outcomes in remote Indigenous communities using the RE-AIM framework.
Answers are grounded in this paper and cite their sources.
Does not alter clinical management in remote Indigenous communities; leaves open the effectiveness of community-based interventions pending review completion.
INTRODUCTION: Indigenous people represent approximately 5% of the world's population. However, they often have a disproportionately higher burden of cardiovascular disease (CVD) risk and chronic kidney disease (CKD) than their equivalent general population. Several non-pharmacological interventions (e.g., educational) have been used to reduce CVD and kidney disease risk factors in Indigenous groups. The aim of this paper is to describe the protocol for a scoping review that will assess the impact of non-pharmacological interventions carried out in Indigenous and remote dwelling populations to reduce CVD risk factors and CKD. MATERIALS AND METHODS: This scoping review will be guided by the methodological framework for conducting scoping studies developed by Arksey and O'Malley. Both empirical (Medline, Embase, Cochrane Library, CINAHL, ISI Web of Science and PsycINFO) and grey literature references will be assessed if they focused on interventions targeted at reducing CVD or CKD among Indigenous groups. Two reviewers will independently screen references in consecutive stages of title/abstract screening and then full-text screening. Impact of interventions used will be assessed using the reach, effectiveness, adoption, implementation, maintenance (RE-AIM) framework. A descriptive overview, tabular summaries, and content analysis will be carried out on the extracted data. ETHICS AND DISSEMINATION: This review will collect and analyse evidence on the impact of interventions of research carried out to reduce CVD and CKD among Indigenous populations. Such evidence will be disseminated using traditional approaches that includes open-access peer-reviewed publication, scientific presentations, and a report. Also, we will disseminate our findings to the government and Indigenous leaders. Ethical approval will not be required for this scoping review as the data used will be extracted from already published studies with publicly accessible data.
No takes yet. Share an insight, caveat, or question.
Okpechi et al. (2022) conducted a review in Cardiovascular disease and chronic kidney disease. Community-based non-pharmacological interventions vs. Control group or baseline was evaluated on Changes in behavioral, clinical, and biochemical cardiovascular risk factors and kidney disease outcomes. Community-based non-pharmacological interventions for cardiovascular and kidney disease outcomes in remote Indigenous communities will be evaluated in this planned scoping review.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: